Kirsten Drejer
Board member
 Pharmaceutical Science
Bionor Labs
Norway
Biography
Kirsten Drejer (born 1956) has been a member of the Board since 2015. She was reelected in March 2016. Mrs. Drejer co-founded Symphogen A/S in 2000 and serves as its Chief Executive Officer. She is also a member of the Board of Directors for Symphogen. Dr. Drejer has 30 years of experience in the pharmaceutical and biotech industry. Before joining Symphogen she held scientific and managerial positions in Novo Nordisk A/S as Corporate Facilitator, Director of Diabetes Discovery and Head of Diabetes Pharmacology. Dr. Drejer is a board member of Vækstfonden (The Fund for Industrial Growth). Dr. Drejer holds a DISPUK diploma in Leadership & Organizational Development.
Research Interest
Pharmaceutical Science
